Strand Therapeutics Website, Blog & Press Pages

Strand Therapeutics Website, Blog & Press Pages - aVenture

Strand Therapeutics - Library

strandtx.comCrawled Oct 15, 2026

Careers & Hiring

1 page

Careers/careers
Strand Therapeutics is developing genetic medicines and has open positions in regulatory sciences, LNP discovery, and other areas in Boston, MA.

About

1 page

About/about
Strand is a clinical-stage biotech company leading the genetic medicine revolution with complex mRNA therapeutics for cancer and autoimmune disease.

Homepage

1 page

Homepage/
Clinical-stage biotech developing breakthrough mRNA therapeutics with targeted delivery systems for solid tumors, autoimmune diseases, and blood cancers.

Coverage

5 items

Strand Therapeutics to Present Preclinical Data on Its Programmable mRNA In Vivo CAR-T Platform at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meetingbusinesswire.com/news/home/20260427295214/en/Strand-Therapeutics-to-Present-Preclinical-Data-on-Its-Programmable-mRNA-In-Vivo-CAR-T-Platform-at-the-29th-American-Society-of-Gene-Cell-Therapy-ASGCT-Annual-Meeting
Strand Therapeutics announces plans to present preclinical data on its programmable mRNA in vivo CAR-T platform at the 29th ASGCT Annual Meeting.
Apr 2026 · Business WireNews article
Strand Therapeutics announces J.P. Morgan Healthcare Conference presentationbusinesswire.com/news/home/20251215101222/en/Strand-Therapeutics-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference
Strand Therapeutics announces plans to present at the 44th Annual J.P. Morgan Healthcare Conference. The announcement does not provide a presentation date, topic, or additional company details.
Dec 2025 · Business WireNews article
Strand Therapeutics promotes Prashant Nambiar and appoints Ethan Cashbusinesswire.com/news/home/20251105520833/en/Strand-Therapeutics-Promotes-Prashant-Nambiar-to-Chief-Scientific-Officer-and-Appoints-Ethan-Cash-as-Senior-Vice-President-Head-of-Portfolio-Management-and-Program-Development
Strand Therapeutics promotes Prashant Nambiar to chief scientific officer and appoints Ethan Cash to lead portfolio management and program development.
Nov 2025 · Business WireNews article
Strand Therapeutics raises $153 million Series Bbusinesswire.com/news/home/20250807475027/en/Strand-Therapeutics-Raises-%24153-Million-Series-B-Financing-to-Further-Advance-Programmable-mRNA-Therapeutic-Pipeline
Strand Therapeutics announces $153 million in Series B financing. The company says the funding will advance its programmable mRNA therapeutic pipeline.
Aug 2025 · Business WireNews article